In 2025, the Indian industry was valued at USD 16.14 billion.
Regional outlook suggests the India Infusion Services Market is expected to be USD 71.29 billion by 2033, registering a CAGR of 20.4% throughout the forecast period.
Private tertiary hospital expansion is materially increasing infusion chair density in metro corridors, particularly for oncology and autoimmune biologics as private insurance penetration rises.
Indian Council of Medical Research cancer registry findings show a steady rise in diagnosed cases, strengthening long-term systemic therapy demand across major oncology hubs.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]